Antimicrobial properties on non-antibiotic drugs in the era of increased bacterial resistance M Lagadinou, MO Onisor, A Rigas, DV Musetescu, D Gkentzi, ... Antibiotics 9 (3), 107, 2020 | 95 | 2020 |
Fatigue and depressive symptoms associated with chronic viral hepatitis patients’ health-related quality of life (HRQOL) K Karaivazoglou, G Iconomou, C Triantos, T Hyphantis, K Thomopoulos, ... Annals of hepatology 9 (4), 419-427, 2010 | 95 | 2010 |
Prognosis of COVID-19: Changes in laboratory parameters M Lagadinou, EE Solomou, N Zareifopoulos, M Marangos, C Gogos, ... Age (yrs) 62 (13.4), 47-16.42, 2020 | 88 | 2020 |
N-acetyl-cysteine reduces the risk for mechanical ventilation and mortality in patients with COVID-19 pneumonia: a two-center retrospective cohort study SF Assimakopoulos, D Aretha, D Komninos, D Dimitropoulou, ... Infectious Diseases 53 (11), 847-854, 2021 | 60 | 2021 |
The use of IgM-enriched immunoglobulin in adult patients with sepsis L Kakoullis, ND Pantzaris, C Platanaki, M Lagadinou, ... Journal of Critical Care 47, 30-35, 2018 | 47 | 2018 |
Intubation and mechanical ventilation of patients with COVID-19: what should we tell them? N Zareifopoulos, M Lagadinou, A Karela, G Karantzogiannis, D Velissaris Monaldi Archives for Chest Disease 90 (1), 2020 | 38 | 2020 |
Procalcitonin and sepsis in the Emergency Department: an update. D Velissaris, N Zareifopoulos, M Lagadinou, C Platanaki, K Tsiotsios, ... European Review for Medical & Pharmacological Sciences 25 (1), 2021 | 37 | 2021 |
Peripheral inserted central catheter use and related infections in clinical practice: a literature update D Velissaris, V Karamouzos, M Lagadinou, C Pierrakos, M Marangos Journal of clinical medicine research 11 (4), 237, 2019 | 35 | 2019 |
Tocilizumab versus baricitinib in hospitalized patients with severe COVID-19: an open label, randomized controlled trial T Karampitsakos, O Papaioannou, P Tsiri, M Katsaras, A Katsimpris, ... Clinical Microbiology and Infection 29 (3), 372-378, 2023 | 30 | 2023 |
Acceptance of hepatitis B vaccination among health care workers in Western Greece K Karaivazoglou, C Triantos, M Lagadinou, C Bikas, M Michailidou, ... Archives of environmental & occupational health 69 (2), 107-111, 2014 | 29 | 2014 |
Neuropsychiatric effects of antiviral drugs N Zareifopoulos, M Lagadinou, A Karela, O Kyriakopoulou, D Velissaris Cureus 12 (8), 2020 | 21 | 2020 |
Alterations in lymphocyte subsets and monocytes in patients diagnosed with SARS-CoV-2 pneumonia: a mini review of the literature. M Lagadinou, N Zareifopoulos, D Gkentzi, F Sampsonas, E Kostopoulou, ... European Review for Medical & Pharmacological Sciences 25 (15), 2021 | 18 | 2021 |
SARS CoV-2-induced viral sepsis: the role of gut barrier dysfunction SF Assimakopoulos, G Eleftheriotis, M Lagadinou, V Karamouzos, ... Microorganisms 10 (5), 1050, 2022 | 17 | 2022 |
Attitudes of school teachers toward influenza and COVID-19 vaccine in Greece during the COVID-19 pandemic D Gkentzi, E Benetatou, A Karatza, A Kanellopoulou, S Fouzas, ... Human vaccines & immunotherapeutics 17 (10), 3401-3407, 2021 | 17 | 2021 |
Management of COVID-19: the risks associated with treatment are clear, but the benefits remain uncertain N Zareifopoulos, M Lagadinou, A Karela, C Platanaki, G Karantzogiannis, ... Monaldi Archives for Chest Disease 90 (2), 2020 | 15 | 2020 |
Recurrent visceral leishmaniasis in an immunocompetent patient: a case report M Lagadinou, D Dimitropoulou, SF Assimakopoulos, G Davoulos, ... Journal of Medical Case Reports 7, 1-4, 2013 | 15 | 2013 |
Septic Thrombophlebitis Caused by Fusobacterium necrophorum in an Intravenous Drug User D Dimitropoulou, M Lagadinou, T Papayiannis, V Siabi, CA Gogos, ... Case reports in infectious diseases 2013, 2013 | 15 | 2013 |
Evaluation of plasma soluble urokinase plasminogen activator receptor levels in patients with COVID-19 and non-COVID-19 pneumonia: an observational cohort study D Velissaris, M Lagadinou, T Paraskevas, E Oikonomou, V Karamouzos, ... Journal of clinical medicine research 13 (9), 474, 2021 | 14 | 2021 |
Efficacy of Fosfomycin-Containing Regimens for Treatment of Bacteremia Due to Pan-Drug Resistant Acinetobacter baumannii in Critically Ill Patients: A Case … SF Assimakopoulos, V Karamouzos, G Eleftheriotis, M Lagadinou, ... Pathogens 12 (2), 286, 2023 | 13 | 2023 |
Pathophysiology and management of Akathisia 70 years after the introduction of the chlorpromazine, the first antipsychotic. N Zareifopoulos, M Katsaraki, P Stratos, V Villiotou, M Skaltsa, A Dimitriou, ... European Review for Medical & Pharmacological Sciences 25 (14), 2021 | 13 | 2021 |